Apolipoprotein E genotype and progression of Alzheimer's disease: The Rotterdam Study

Journal of Neurology

Volumn 246, Issue 4, 1999, Pages 304-308

  Slooter, Arjen J C ^a   Houwing Duistermaat, Jeanine J ^a   Van Harskamp, Frans ^a   Cruts, Marc ^b   Van Broeckhoven, Christine ^b   Breteler, Monique M B ^a   Hofman, Albert ^a   Stijnen, Theo ^a   Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Alzheimer's disease; Apolipoprotein E; Progression; Survival

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SYMPTOM;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION; COHORT STUDIES; DEMENTIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0032925059     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050351     Document Type: Article

References (26)

1. 1. Basun H, Grut M, Winblad B, Lannfelt L (1995) Apolipoprotein ε4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 183:32-34
2. 2. Bronzova J, Van Duijn CM, Havekes LM, De Knijff P, Van Broeckhoven C, Hofman A (1996) Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease. J Neurol 243:465-468
3. 3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE, Gusella JE, Small GW, Roses AD, Pericak-Vance MA, Haines JL (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45:1323-1328
4. 4. Dal Forno G, Rasmusson X, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH (1996) Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 53:345-350
5. 5. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance M, Risch N, Van Duijn CM for the APOE and Alzheimer Disease Meta Analysis Consortium (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 278:1349-1356
6. 6. Folstein MS, Folstein SE, McHugh PR (1975) "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
7. 7. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M (1995) Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 37:596-604
8. 8. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51:888-895
9. 9. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT (1996) Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 39:62-70
10. 10. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT (1996) Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 47:444-448
11. 11. Hofman A, Grobbee DE, De Jong PTVM, Van den Ouweland FA (1991) Determinants of disease and disability in the elderly. The Rotterdam Elderly Study. Eur J Epidemiol 7:403-422
12. 12. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572
13. 13. Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Müller U (1996) Apolipoprotein E ε4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 47: 440-443
14. 14. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38:963-974
15. 15. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala E-L, Hartikainen P, Hänninen T, Ryynänen, Riekkinen PJ (1996) Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease. Relation to apolipoprotein E polymorphism. Neurology 46:413-419
16. 16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
17. 17. Ott A, Breteler MMB, Van Harskamp F, Claus JJ, Van der Cammen TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education: the Rotterdam Study. BMJ 310: 970-973
18. 18. Ott A, Breteler MMB, Van Harskamp F, Stijnen Th, Hofman A (1998) The incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147: 574-580
19. 19. Plassman BL, Breitner JCS (1996) Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology 47: 317-320
20. 20. Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP, Stern Y, Mayeux R (1996) A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 47:256-259
21. 21. Slooter AJC, Cruts M, Kalmijn S, Hofman A, Breteler MMB, Van Broeckhoven C, Van Duijn CM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55:964-968
22. 22. Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R (1997) The absence of an apolipoprotein ε4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 41:615-620
23. 23. Stern Y, Tang M-X, Denaro J, Mayeux R (1995) Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 37:590-595
24. 24. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981
25. 25. Van der Cammen TJM, Verschoor CJ, Van Loon CPM, Van Harskamp F, De Koning I, Schudel WJ, Slooter AJC, Van Broeckhoven C, Van Duijn C (1998) Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE*4 allele. J Am Geriatr Soc 46:962-967
26. 26. Van Duijn CM, De Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C (1995) The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37:605-610